Company news
Memphasys Ltd (ASX:MEM) news
Every Memphasys Ltd press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Felix Registration Achieved in Vietnam and Cartridge Order
August 19, 2026
European Commercial Roll-out continues with Poland Agreement
August 4, 2026
Exclusive Thailand Commercialisation Agreement Secured
June 30, 2026
UK Market Entry & Acceleration of Commercial Expansion
June 24, 2026
Successful $1.2M Placement and Convertible Note Extended
June 17, 2026
Memphasys Executes Supply Agreement with Monash IVF Group
June 15, 2026
South-East Asian Commercialization Agreement Secured
May 31, 2026
ITL Orders 1000 Felix Cartridges Across MENA Markets
May 26, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
April 16, 2026
Investor Presentation - April 2026
April 7, 2026
MENA Orders Secured, Expanded & Operations Unaffected
March 19, 2026
Appendix 4D - Half-year Financial Report - 31 December 2025
February 27, 2026
Memphasys Secures TGA Approval for Felix System
February 8, 2026
Memphasys announces successful $800,000 Capital Raising
February 5, 2026
Trading Halt
February 3, 2026
Regulatory Submissions Lodged for Felix
February 2, 2026
Qatar's largest IVF Institution Places MENA Orders for Felix
February 1, 2026
Memphasys Extends Convertible Note Repayment Terms
December 30, 2025
Placement of Shortfall Securities from the Entitlement Offer
December 29, 2025
Memphasys Secures CE Mark Approval for Felix System
December 28, 2025
Memphasys Secures Long-Term European Supply Agreement
December 21, 2025
Key MENA Partner Secures Early Felix Cartridge Order
December 17, 2025
Memphasys Implements Leadership Restructure
December 9, 2025
Felix Middle East Direct Sales Strategy
December 7, 2025
Completion of Entitlement Offer
November 9, 2025
MEM Secures Indian Supply Deal Under Go-Direct Strategy
October 27, 2025
Memphasys Expands Felix Commercial Footprint in Japan
October 23, 2025
Response to ASX Aware Letter
October 19, 2025
Non-Renounceable Issue
October 1, 2025
LR4.3D - adjustment to financial statements
September 30, 2025
Investor Presentation - commercialisation of FELIX
September 25, 2025
Placement Accelerates Felix Commercialisation and Manufactur
September 21, 2025
Memphasys Secures Significant ITL Contract Upgrade
September 17, 2025
FELIX landmark commercial agreement signed for MENA region
September 7, 2025
Preliminary Final Report
August 28, 2025
Presentation to Shareholders at General Meeting
August 8, 2025
CE Mark Lodged for Felix to Expand Global Access
June 29, 2025
MEM Successfully trials RoXsta Mega Cell High-Throughput
May 7, 2025
$1.275M Placement to Accelerate Commercial Rollout
April 14, 2025
Pause in Trading
April 10, 2025
RoXsta offers Effective Oxidative Stress Measurem't 4 Cattle
April 2, 2025
Felix Trial Confirms Best-in-Class Performance
March 23, 2025
Half Yearly Report and Accounts
February 28, 2025
Extension of Convertible Notes
February 28, 2025
Felix Data lock complete and regulatory submission commenced
February 23, 2025
Leading Brazilian Andrology Clinic to test Felix System
February 16, 2025
Felix Clinical Trial complete, Data Lock expected in 2 weeks
February 10, 2025
Publication Highlights Diagnostic Potential of RoXsta TM
January 15, 2025
Heranova Felix System Utilisation Testing commences in China
January 5, 2025
Bovine Study commences to assess RoXsta antioxidant system
December 19, 2024